The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Targeted Killing of Cancer Cells in Vivo and in Vitro with EGF-Directed Carbon Nanotube-Based Drug Delivery
Open accessAbstract
Carbon nanotube-based drug delivery holds great promise for cancer therapy. Herein we report the first targeted, in vivo killing of cancer cells using a drug-single wall carbon nanotube (SWNT) bioconjugate, and demonstrate efficacy superior to nontargeted bioconjugates. First line anticancer agent cisplatin and epidermal growth factor (EGF) were attached to SWNTs to specifically target squamous cancer, and the nontargeted control was SWNT-cisplatin without EGF. Initial in vitro imaging studies with head and neck squamous carcinoma cells (HNSCC) overexpressing EGF receptors (EGFR) using Qdot luminescence and confocal microscopy showed that SWNT-Qdot-EGF bioconjugates internalized rapidly into the cancer cells. Limited uptake occurred for control cells without EGF, and uptake was blocked by siRNA knockdown of EGFR in cancer cells, revealing the importance of EGF-EGFR binding. Three color, two-photon intravital video imaging in vivo showed that SWNT-Qdot-EGF injected into live mice was selectively taken up by HNSCC tumors, but SWNT-Qdot controls with no EGF were cleared from the tumor region in <20 min. HNSCC cells treated with SWNT-cisplatin-EGF were also killed selectively, while control systems that did not feature EGF-EGFR binding did not influence cell proliferation. Most significantly, regression of tumor growth was rapid in mice treated with targeted SWNT-cisplatin-EGF relative to nontargeted SWNT-cisplatin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, R., Yang, X., Zhang, Z., Zhang, Y., Wang, S., Cai, Z., Jia, Y., Ma, Y., Zheng, C., Lu, Y., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302808 · Cited by 98
RetractedThe resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Argiris, A., Karamouzis, M. V., Raben, D., & Ferris, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60728-x · Cited by 2,224
Carbon Nanotubes: Synthesis, Integration, and Properties
Dai, H. (2002) · Accounts of Chemical Research · doi:10.1021/ar0101640 · Cited by 1,932
(2001) · Topics in Applied Physics · doi:10.1007/3-540-39947-x · Cited by 1,748
Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors
Chen, R. J., Bangsaruntip, S., Drouvalakis, K. A., Wong Shi Kam, N., Shim, M., Li, Y., Kim, W., Utz, P. J., & Dai, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837064100 · Cited by 1,442
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2006.170 · Cited by 1,436
Cited by
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Nanoparticles as drug delivery systems
Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Carbon nanotubes: properties, synthesis, purification, and medical applications
Eatemadi, A., Daraee, H., Karimkhanloo, H., Kouhi, M., Zarghami, N., Akbarzadeh, A., Abasi, M., Hanifehpour, Y., & Joo, S. W. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-393 · Cited by 1,239
Sub-nanometre sized metal clusters: from synthetic challenges to the unique property discoveries
Lu, Y., & Chen, W. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15325d · Cited by 1,152
Promises, facts and challenges for carbon nanotubes in imaging and therapeutics
Kostarelos, K., Bianco, A., & Prato, M. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.241 · Cited by 787
Carbon materials for drug delivery & cancer therapy
Liu, Z., Robinson, J. T., Tabakman, S. M., Yang, K., & Dai, H. (2011) · Materials Today · doi:10.1016/s1369-7021(11)70161-4 · Cited by 600
New Generation Cadmium-Free Quantum Dots for Biophotonics and Nanomedicine
Xu, G., Zeng, S., Zhang, B., Swihart, M. T., Yong, K.-T., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00290 · Cited by 587
Carbon nanotubes for delivery of small molecule drugs
Wong, B. S., Yoong, S. L., Jagusiak, A., Panczyk, T., Ho, H. K., Ang, W. H., & Pastorin, G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.005 · Cited by 585
Gold nanoparticles: opportunities and challenges in nanomedicine
Arvizo, R., Bhattacharya, R., & Mukherjee, P. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003777010 · Cited by 538
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Quantum dots as a platform for nanoparticle drug delivery vehicle design
Probst, C. E., Zrazhevskiy, P., Bagalkot, V., & Gao, X. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.036 · Cited by 466
Receptor-targeted nanocarriers for therapeutic delivery to cancer
Yu, B., Tai, H. C., Xue, W., Lee, L. J., & Lee, R. J. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.521200 · Cited by 423
Biological interactions of carbon-based nanomaterials: From coronation to degradation
Bhattacharya, K., Mukherjee, S. P., Gallud, A., Burkert, S. C., Bistarelli, S., Bellucci, S., Bottini, M., Star, A., & Fadeel, B. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.11.011 · Cited by 402
Functionalized carbon nanotubes for potential medicinal applications
Zhang, Y., Bai, Y., & Yan, B. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.04.005 · Cited by 396
Nanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
Gurunathan, S., Kang, M.-H., Qasim, M., & Kim, J.-H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103264 · Cited by 367
Carbon Nanotubes in Cancer Therapy and Drug Delivery
Elhissi, A. M. A., Ahmed, W., Hassan, I. U., Dhanak, V. R., & D'Emanuele, A. (2012) · Journal of Drug Delivery · doi:10.1155/2012/837327 · Cited by 332
Advancement in carbon nanotubes: basics, biomedical applications and toxicity
Beg, S., Rizwan, M., Sheikh, A. M., Hasnain, M. S., Anwer, K., & Kohli, K. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01167.x · Cited by 306
Su, Y., Hu, M., Fan, C., He, Y., Li, Q., Li, W., Wang, L.-H., Shen, P., & Huang, Q. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.074 · Cited by 277
Delivery of drugs and biomolecules using carbon nanotubes
Vashist, S. K., Zheng, D., Pastorin, G., Al-Rubeaan, K., Luong, J. H. T., & Sheu, F.-S. (2011) · Carbon · doi:10.1016/j.carbon.2011.05.049 · Cited by 277
Carbon nanomaterials: multi-functional agents for biomedical fluorescence and Raman imaging
Bartelmess, J., Quinn, S. J., & Giordani, S. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00306c · Cited by 259
The state-of-play and future of platinum drugs
Apps, M. G., Choi, E. H. Y., & Wheate, N. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0237 · Cited by 256
Kolarcik, C. L., Catt, K., Rost, E., Albrecht, I. N., Bourbeau, D., Du, Z., Kozai, T. D. Y., Luo, X., Weber, D. J., & Tracy Cui, X. (2015) · Journal of Neural Engineering · doi:10.1088/1741-2560/12/1/016008 · Cited by 126
Nagai, H., & Toyokuni, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02326.x · Cited by 98
Functionalized carbon nanotubes for anticancer drug delivery
Lay, C. L., Liu, J., & Liu, Y. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.11.34 · Cited by 71
Specific cell targeting with APRPG conjugated PEG–PLGA nanoparticles for treating ovarian cancer
Wang, Y., Liu, P., Duan, Y., Yin, X., Wang, Q., Liu, X., Wang, X., Zhou, J., Wang, W., Qiu, L., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.062 · Cited by 56
PEGylated Single-Walled Carbon Nanotubes as Nanocarriers for Cyclosporin A Delivery
Hadidi, N., Kobarfard, F., Nafissi-Varcheh, N., & Aboofazeli, R. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-9944-2 · Cited by 39
EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model
Zalba, S., Contreras, A. M., Merino, M., Navarro, I., de Ilarduya, C. T., Trocóniz, I. F., Koning, G., & Garrido, M. J. (2016) · Nanomedicine · doi:10.2217/nnm.15.208 · Cited by 26
Metadata
- Authors
- Bhirde, A. A., Patel, V., Gavard, J., Zhang, G., Sousa, A. A., Masedunskas, A., Leapman, R. D., Weigert, R., Gutkind, J. S., & Rusling, J. F.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-01-13
- Volume
- 3
- Issue
- 2
- Pages
- 307-316
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2092329959
- Cited by
- 853
- References
- 53
- FWCI
- 43.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.